Eagle Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $49.8M | Sell |
|
|||||
|
2024
Q2 | $106M | Sell |
|
|||||
|
2024
Q1 | $136M | Sell |
|
|||||
|
2023
Q4 | $124M | Buy |
|
|||||
|
2023
Q3 | $132M | Sell |
|
|||||
|
2023
Q2 | $134M | Buy |
|
|||||
|
2023
Q1 | $109M | Buy |
|
|||||
|
2022
Q4 | $51.8M | Sell |
|
|||||
|
2022
Q3 | $60.9M | Buy |
|
|||||
|
2022
Q2 | $74.6M | Sell |
|
|||||
|
2022
Q1 | $130M | Buy |
|
|||||
|
2021
Q4 | $147M | Buy |
|
|||||
|
2021
Q3 | $132M | Buy |
|
|||||
|
2021
Q2 | $92.2M | Sell |
|
|||||
|
2021
Q1 | $73.2M | Buy |
|
|||||
|
2020
Q4 | $68.8M | Sell |
|
|||||
|
2020
Q3 | $73.4M | Sell |
|
|||||
|
2020
Q2 | $59.8M | Buy |
|
|||||
|
2020
Q1 | $8.23M | Buy |
|
|||||
|
2019
Q4 | $4.03M | Sell |
|
|||||
|
2019
Q3 | $7.18M | Sell |
|
|||||
|
2019
Q2 | $42.4M | Sell |
|
|||||
|
2019
Q1 | $41M | Sell |
|
|||||
|
2018
Q4 | $36.9M | Sell |
|
|||||
|
2018
Q3 | $47.1M | Sell |
|
|||||
|
2018
Q2 | $50.4M | Sell |
|
|||||
|
2018
Q1 | $53.9M | Sell |
|
|||||
|
2017
Q4 | $69.8M | Sell |
|
|||||
|
2017
Q3 | $86.1M | Sell |
|
|||||
|
2017
Q2 | $104M | Sell |
|
|||||
|
2017
Q1 | $109M | Buy |
|
|||||
|
2016
Q4 | $107M | Sell |
|
|||||
|
2016
Q3 | $94.4M | Buy |
|
|||||
|
2016
Q2 | $83.7M | Sell |
|
|||||
|
2016
Q1 | $82.9M | Sell |
|
|||||
|
2015
Q4 | $74.3M | Buy |
|
|||||
|
2015
Q3 | $49.4M | Sell |
|
|||||
|
2015
Q2 | $53.8M | Buy |
|
|||||
|
2015
Q1 | $47.4M | Buy |
|
|||||
|
2014
Q4 | $17.3M | Sell |
|
|||||
|
2014
Q3 | $17.8M | Sell |
|
|||||
|
2014
Q2 | $23M | Buy |
|
|||||
|
2014
Q1 | $20M | Buy |
|
|||||
|
2013
Q4 | $12.2M | Buy |
|
|||||
|
2013
Q3 | $2.75M | Sell |
|
|||||
|
2013
Q2 | $2.39M | Buy |
|